LAA Closure in 2015
LAA closure is seen as an alternative for patients who are at risk of stroke due to nonvalvular atrial fibrillation What is the data behind this? What devices are present? What is upcoming for this technology? These are the questions that we hope to answer.
- What is the risk of stroke in atrial fibrillation?
- What is the data behind LAA closure?
- What devices and techniques are available for LAA closure?
- What future directions are available for this field?
- primary care physicians
Dr Sameer Gafoor is the Medical Director of Structural Heart Diseases at Swedish Medical Center in Seattle, WA, US. He trained at Northwestern University of Medicine for his internal medicine residency, Georgetown/Washington Hospital Center for cardiovascular disease, and Emory for his interventional cardiology fellowship. He also studied under Dr Horst Sievert at the CardioVascular Center Frankfurt.
Dr Gafoor is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).